MXPA03003911A - Polvo en contra de los hongos que tiene propiedades de excipiente mejoradas. - Google Patents
Polvo en contra de los hongos que tiene propiedades de excipiente mejoradas.Info
- Publication number
- MXPA03003911A MXPA03003911A MXPA03003911A MXPA03003911A MXPA03003911A MX PA03003911 A MXPA03003911 A MX PA03003911A MX PA03003911 A MXPA03003911 A MX PA03003911A MX PA03003911 A MXPA03003911 A MX PA03003911A MX PA03003911 A MXPA03003911 A MX PA03003911A
- Authority
- MX
- Mexico
- Prior art keywords
- enhanced
- excipient
- fungal powder
- excipient properties
- properties
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/12—Face or body powders for grooming, adorning or absorbing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
Esta descrito un polvo para el cuerpo. El polvo para el cuerpo incluye un agente anti-fungal topico en combinacion con por lo menos dos excipientes. Un excipiente es un material en particulas de nitrido de boro recubierto con un compuesto de silicona. El otro excipiente es una fragancia atrapada molecularmente dentro del compuesto de ciclodextrina.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/161,157 US6824763B2 (en) | 2002-05-30 | 2002-05-30 | Anti-fungal powder having enhanced excipient properties |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03003911A true MXPA03003911A (es) | 2004-10-15 |
Family
ID=29583367
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03003911A MXPA03003911A (es) | 2002-05-30 | 2003-05-02 | Polvo en contra de los hongos que tiene propiedades de excipiente mejoradas. |
Country Status (2)
Country | Link |
---|---|
US (1) | US6824763B2 (es) |
MX (1) | MXPA03003911A (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1598073A1 (de) * | 2004-02-02 | 2005-11-23 | Universitätsklinikum Freiburg | Korianderöl und dieses enthaltende Zubereitungen mit antimikrobieller und antiphlogistischer Wirkung und deren Verwendung |
WO2007047253A2 (en) * | 2005-10-11 | 2007-04-26 | Eastman Chemical Company | Pharmaceutical formulations of cyclodextrins and antifungal azole compounds |
US20080220103A1 (en) * | 2005-10-24 | 2008-09-11 | Jay Birnbaum | Method for treating/controlling/killing fungi and bacteria on living animals |
CA2647374A1 (en) * | 2005-10-24 | 2007-05-03 | Staval Pharma, Ltd. | Method for treating/controlling/killing fungi and bacteria |
US8663665B2 (en) | 2006-03-02 | 2014-03-04 | Momentive Performance Materials Inc. | Anti-chafing compositions comprising boron nitride |
US20080057009A1 (en) * | 2006-08-30 | 2008-03-06 | Michael Brett Grunhaus | Talc-based sand removing sun care powder. |
US10149910B2 (en) | 2007-03-01 | 2018-12-11 | The Procter & Gamble Plaza | Compositions and/or articles comprising cyclodextrin complexing material |
US11090250B2 (en) | 2007-03-01 | 2021-08-17 | The Procter & Gamble Company | Compositions and/or articles comprising cyclodextrin complexing material |
US7790202B1 (en) * | 2007-04-09 | 2010-09-07 | Martell Helen D | Multi-purpose skin composition |
US20090149361A1 (en) * | 2007-12-11 | 2009-06-11 | Emily Kathleen Adkison | Personal cleansing kit for promoting relaxation and sleep, reducing stress and decreasing muscle tightness |
ES2838524T3 (es) * | 2012-04-25 | 2021-07-02 | Oreal | Aceite esencial de Achillea, composición cosmética que lo comprende y sus usos |
US11458049B2 (en) | 2016-09-06 | 2022-10-04 | The Procter & Gamble Company | Absorbent articles including perfume and cyclodextrins |
MX2019002544A (es) | 2016-09-06 | 2019-07-01 | Procter & Gamble | Composiciones en aerosol. |
CA3035350C (en) | 2016-09-06 | 2023-05-23 | The Procter & Gamble Company | Antiperspirant and deodorant compositions comprising a hydrophilic perfume compound complexed in a cyclodextrin |
US10758476B1 (en) * | 2017-09-18 | 2020-09-01 | Type A Brands, Llc | Deodorant with sweat-activated technology |
CN108066228B (zh) * | 2018-02-09 | 2020-06-12 | 杭州纳美智康科技有限公司 | 一种保湿抗菌沐浴露及其制备方法 |
CN112587462B (zh) * | 2021-01-08 | 2023-04-14 | 中华全国供销合作总社南京野生植物综合利用研究所 | 一种芫荽提取物的应用、抗紫外抗氧化美白化妆品及其制备方法 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4818614A (en) | 1985-07-29 | 1989-04-04 | Shiseido Company Ltd. | Modified powder |
US4801445A (en) | 1985-07-29 | 1989-01-31 | Shiseido Company Ltd. | Cosmetic compositions containing modified powder or particulate material |
JPH0819004B2 (ja) | 1986-12-26 | 1996-02-28 | 日清製粉株式会社 | 徐放性医薬製剤 |
US4880774A (en) | 1987-04-14 | 1989-11-14 | Kurita Water Industries, Ltd. | Sustained release aromatic |
IT1203968B (it) | 1987-04-24 | 1989-02-23 | Bononi Ricerca | Complessi di b-ciclodestrina ad attivita' antimicotica |
AU608891B2 (en) | 1987-09-24 | 1991-04-18 | Merck & Co., Inc. | Solubility modulated drug delivery device |
US5476852A (en) | 1989-05-03 | 1995-12-19 | Janssen Pharmaceutica N.V. | Method of topically treating acne vulgaris, hyperkeratotic dermatoses, and photo-aging of the skin |
US5658956A (en) | 1991-03-01 | 1997-08-19 | Warner-Lambert Company | Bioadhesive-wound healing compositions and methods for preparing and using same |
US5246780A (en) | 1991-08-29 | 1993-09-21 | L'oreal | Coated particle for use in cosmetic preparations and method |
US5324718A (en) | 1992-07-14 | 1994-06-28 | Thorsteinn Loftsson | Cyclodextrin/drug complexation |
US5472954A (en) | 1992-07-14 | 1995-12-05 | Cyclops H.F. | Cyclodextrin complexation |
FR2695558B1 (fr) | 1992-09-11 | 1994-10-21 | Oreal | Composition cosmétique contenant des particules solides revêtues avec un polymère amphotère. |
US5576016A (en) | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
JPH07115003A (ja) * | 1993-10-15 | 1995-05-02 | Matsushita Electric Ind Co Ltd | チップ抵抗器の製造方法 |
TW438601B (en) | 1994-05-18 | 2001-06-07 | Janssen Pharmaceutica Nv | New mucoadhesive emulsion compositions and a process for the preparation thereof |
IL115693A (en) | 1994-10-25 | 2000-08-13 | Revlon Consumer Prod Corp | Cosmetic compositions with improved transfer resistance |
US5696164A (en) | 1994-12-22 | 1997-12-09 | Johnson & Johnson Consumer Products, Inc. | Antifungal treatment of nails |
JPH11502495A (ja) | 1995-01-31 | 1999-03-02 | ローベルト ボツシユ ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | 疎水化された表面を有するセラミック粉末、その製造方法および使用法 |
US5665364A (en) | 1995-07-24 | 1997-09-09 | The Procter & Gamble Company | Compositions for topical delivery of active ingredients |
US5607980A (en) | 1995-07-24 | 1997-03-04 | The Procter & Gamble Company | Topical compositions having improved skin feel |
US5723420A (en) | 1996-03-04 | 1998-03-03 | The Procter & Gamble Company | Personal cleansing bar compositions which contain a fragrance-releasing complex for improved fragrance delivery |
CA2250962C (en) | 1996-04-04 | 2003-06-03 | Nanophase Technologies Corporation | Siloxane star-graft polymers, ceramic powders coated therewith and method of preparing coated ceramic powders |
JPH11508612A (ja) | 1996-05-02 | 1999-07-27 | ザ、プロクター、エンド、ギャンブル、カンパニー | 分散した界面活性剤錯体を含む局所用組成物 |
WO1998011877A1 (en) * | 1996-09-18 | 1998-03-26 | Dragoco, Inc. | Liposome encapsulated active agent dry powder composition |
US5993967A (en) | 1997-03-28 | 1999-11-30 | Nanophase Technologies Corporation | Siloxane star-graft polymers, ceramic powders coated therewith and method of preparing coated ceramic powders |
US6046177A (en) | 1997-05-05 | 2000-04-04 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
DE69810803T2 (de) | 1997-10-24 | 2003-12-24 | The Procter & Gamble Co., Cincinnati | Reinigungs- und konditionierungsgegenstand für die haut oder das haar, mit erhöhter duftfreisetzung |
US6004584A (en) * | 1998-03-02 | 1999-12-21 | The Procter & Gamble Company | Highly absorbent body powders |
US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
AU5146600A (en) | 1999-05-27 | 2000-12-18 | Procter & Gamble Company, The | Topical compositions providing improved treatment of skin or scalp fungal infections |
DE60041699D1 (de) | 1999-06-25 | 2009-04-16 | Procter & Gamble | Topische antimikrobielle zusammensetzungen |
AU5975700A (en) | 1999-07-02 | 2001-01-22 | Janssen Pharmaceutica N.V. | Nasal formulation of an antifungal |
US6514504B1 (en) * | 1999-08-18 | 2003-02-04 | The Procter & Gamble Company | Discontinuous films from skin care compositions |
GB9920167D0 (en) | 1999-08-25 | 1999-10-27 | Avery Dennison Corp | Pressure sensitive adhesive compositions |
US7208463B2 (en) * | 2000-06-02 | 2007-04-24 | The Procter & Gamble Company | Fragrance compositions |
-
2002
- 2002-05-30 US US10/161,157 patent/US6824763B2/en not_active Expired - Fee Related
-
2003
- 2003-05-02 MX MXPA03003911A patent/MXPA03003911A/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
US20030224063A1 (en) | 2003-12-04 |
US6824763B2 (en) | 2004-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03003911A (es) | Polvo en contra de los hongos que tiene propiedades de excipiente mejoradas. | |
EP1507556A4 (en) | CALICHEAMICINE DERIVATIVE VECTOR-TYPE CONJUGATES | |
PL388076A1 (pl) | Doustna postać dawki o przedłużonym uwalnianiu oksykodonu i jej zastosowanie | |
IL215981A0 (en) | An antibody-drug conjugate, an article or manufacture and pharmaceutical compositions comprising thereof | |
MXPA03009797A (es) | ANTICUERPOS PARA BLOQUEO DE PROTEiNA CRIPTO Y USO DE LOS MISMOS. | |
DE60208177D1 (de) | Propylenpolymerzusammensetzung, formkörper und polyolefincopolymer | |
IL219671A0 (en) | 1,2- benzoxazoles and use thereof in the preparation of a medicament | |
AU2001256184A1 (en) | 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases | |
DE602004015134D1 (de) | Saugfähige artikel mit metallbeladenen nanoteilchen | |
BR9915457B1 (pt) | composições de moldagem, uso e artigo. | |
AU2003289641A1 (en) | The novel coumarin-amide derivatives and its preparation, said drug composition and its use | |
IL157965A0 (en) | Cytotoxic cd44 antibody immunoconjugates | |
CA103970S (en) | Blister pack | |
DE60314265D1 (de) | Pharmazeutische zusammensetzungen mit modafinil | |
DE69923336D1 (de) | Oral anzuwendende buprenorphinhaltige arzneimittel | |
PL394604A1 (pl) | Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna | |
GB2368525B (en) | Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease | |
AU2001235783A1 (en) | Therapeutic compositions for pulmonary delivery | |
HRP20050142A2 (en) | Steroid conjugates, preparation thereof and the use thereof | |
CA105215S (en) | Packaging with cosmetic composition | |
AU2001258443A1 (en) | Drug delivery device, especially for the delivery of gestodene | |
DE60111503D1 (de) | Pharmazeutische zusammensetzungen enthaltend terbinafin | |
ATE286748T1 (de) | Medizinische verbandmittel enthaltend zinkoxid mit antimikrobieller wirkung | |
USD474841S1 (en) | Dosage device | |
HRP20040691A2 (en) | 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |